Plant derivatives in the treatment of alcohol dependency.
Amir H Rezvani, David H Overstreet, Marina Perfumi, Maurizio Massi
Pharmacology, Biochemistry, and Behavior June 1, 2003 DOI: 10.1016/s0091-3057(03)00124-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Population | Alcohol-preferring rats (P, msP, HAD, FH strains) |
| Interventions | ibogaine ibogaine analog puerarin daidzin daidzein |
| Citations | 95 |
| Key findings | Pure compounds and extracts from St. John's wort, kudzu, and ibogaine suppress alcohol intake in alcohol-preferring rats with minimal effects on food intake. |
Abstract
The present review summarizes the findings of the effects of extracts of purified compounds from several plants on alcohol intake in alcohol-preferring rats. These include St. John's wort (Hypericum perforatum, HPE), kudzu (Pueraria lobata) and ibogaine (Tabernanthe iboga). Alcohol-preferring (P), Marchigian Sardinian (msP), high-alcohol-drinking (HAD), Fawn-Hooded (FH) rats were allowed to drink alcohol or water voluntarily to establish baseline levels. Pure compounds (puerarin, daidzin, daidzein or analogs) isolated from kudzu, extracts from HPE or ibogaine and its analog were given by either intraperitoneal or oral administration. After acute administration, all agents dose-dependently reduced alcohol intake with minimal effects on food intake. Puerarin and HPE were also effective following chronic treatment. Overall, it is clear that pure compounds (daidzin, puerarin), extracts from St. John's wort, ibogaine and an ibogaine analog suppress alcohol intake in animal models of excessive drinking with minimal effects on other appetitive behaviors. Although the true mechanisms of action of these compounds on alcohol intake are not fully understood, with the current information, it appears that these compounds exert their effects by modulating several neuronal systems implicated in drinking behavior. However, their role in the future of pharmacotherapy for alcoholism will depend upon the outcome of carefully conducted clinical trials.
Citations in the library
Cited by 4
- Complementary medicines in psychiatry: review of effectiveness and safety. The British Journal of Psychiatry February 1, 2006
- Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity Journal of Ethnopharmacology November 22, 2021
- Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment. Addiction Biology September 1, 2006
- Ibogaine for Substance Use Disorders. Advances in Therapy October 14, 2026
Cites 10
- Effects and aftereffects of ibogaine on morphine self-administration in rats. European Journal of Pharmacology April 3, 1991
- Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Research February 7, 1992
- Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats. Pharmacology, Biochemistry, and Behavior November 1, 1995
- Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. European Journal of Pharmacology June 18, 1991
- 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain Research May 6, 1996
and 5 more in the library